<DOC>
	<DOCNO>NCT00374725</DOCNO>
	<brief_summary>In trial test hypothesis probiotic containing Lactobacillus acidophilus Lactobacillus rhamnosus effective therapy patient ulcerative colitis .</brief_summary>
	<brief_title>Treatment Ulcerative Colitis With Combination Lactobacillus Rhamnosus Lactobacillus Acidophilus .</brief_title>
	<detailed_description>In recent year increase interest relationship gastrointestinal flora gut function . Several study show promising result use probiotics patient inflammatory bowel disease . In trial approximately 100 patient ulcerative colitis receive treatment probiotic placebo 8 10 month adjuvant therapy . The trial double-blind , randomise control .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>Patients know ulcerative colitis At least one prior flare disease Clinically endoscopically active disease Age : 18 Changes azathioprine dosage within last three month Patients toxic megacolon , peritoneal reaction severe colonic bleed Known immunodeficiency Ongoing infectious disease Ongoing treatment NSAID cholestyramine Pregnant og lactate woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2002</verification_date>
	<keyword>Ulcerative Colitis</keyword>
	<keyword>Probiotic</keyword>
	<keyword>Placebo control trial</keyword>
	<keyword>Lactobacillus rhamnosus</keyword>
	<keyword>Lactobacillus acidophilus</keyword>
</DOC>